![](/img/cover-not-exists.png)
STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability
Luo, T., Masson, K., Jaffe, J. D., Silkworth, W., Ross, N. T., Scherer, C. A., Scholl, C., Frohling, S., Carr, S. A., Stern, A. M., Schreiber, S. L., Golub, T. R.Volume:
109
Language:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.1120589109
Date:
February, 2012
File:
PDF, 1.54 MB
english, 2012